Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Intensive Induction (R-MegaCHOP/ESHAP)Followed By Intensive Consolidation (BEAM) In Treatment Of High-Risk Aggressive B-Cell Lymphomas

NCT00558220 is registered in ClinicalTrials.gov with Czech Lymphoma Study Group as lead sponsor.

NCT NCT00558220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00558220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Intensive Induction (R-MegaCHOP/ESHAP)Followed By Intensive Consolidation (BEAM) In Treatment Of High-Risk Aggressive B-Cell Lymphomas
Lead sponsor
Czech Lymphoma Study Group
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2002
Completion date
October 31, 2006
Enrollment
106 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma., follicular lymphoma grade iii, primary mediastinal b-cell lymphoma